IDiyas

For the Inventor, By the Inventor

Essen, Germany

Swen Allerheiligen

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 11.0

ph-index = 4

Forward Citations = 39(Granted Patents)


Company Filing History:

goldMedal5 out of 721 
 
Bayer Intellectual Property Gmbh
 patents
silverMedal4 out of 76 
 
Bayer Healthcare Aktiengesellschaft
 patents
bronzeMedal2 out of 378 
 
Bayer Pharma Aktiengesellschaft
 patents
4. 1 out of 192 
 
Bayer Schering Pharma Ag
 patents

Years Active: 2007-2016

Loading Chart...
Loading Chart...
12 patents (USPTO):
1. 9493472 - Substituted benzoxazoles (2016-11-15),
2. 8846934 - Substituted oxazolidinones and their use (2014-09-30),
3. 8487111 - Substituted oxazolidinones and their use (2013-07-16),
4. 8383822 - Substituted oxazolidinones and their use (2013-02-26),
5. 8263624 - Aryl-substituted heterocycles, and use thereof (2012-09-11),
6. 8198267 - Substituted oxazolidinones and their use (2012-06-12),
7. 8173665 - I-pheny 1-3,4-dihydropyrimidin-2(1H)-one derivatives and their use (2012-05-08),
8. 7691854 - Dihydropyridine derivatives for use as human neutrophil elastase inhibitors (2010-04-06),
9. 7687510 - Pyrimidinone derivatives as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes (2010-03-30),
10. 7566723 - 1-phenyl1-3,4-dihydropyrimidin-2(1H)-one derivatives and their use (2009-07-28),
11. 7230017 - Dihydropyridinone derivatives (2007-06-12),
12. 7199136 - 1,4-dihydro-1,4-diphenylpyridine derivatives (2007-04-03),

Title: Swen Allerheiligen: Innovator in Medicinal Chemistry

Introduction

Swen Allerheiligen is a prominent inventor based in Essen, Germany. He has made significant contributions to the field of medicinal chemistry, holding a total of 12 patents. His work primarily focuses on developing novel compounds for the treatment of various diseases, particularly cardiovascular disorders.

Latest Patents

Among his latest patents, Allerheiligen has developed substituted benzoxazoles. This invention relates to substituted benzoxazoles and processes for their preparation, as well as their use in creating medicaments for the treatment and/or prophylaxis of diseases, especially cardiovascular disorders, including thrombotic or thromboembolic disorders. Another notable patent involves substituted oxazolidinones, which are novel compounds that can be used for the treatment and/or prophylaxis of diseases, particularly thromboembolic disorders.

Career Highlights

Throughout his career, Allerheiligen has worked with notable companies such as Bayer Intellectual Property GmbH and Bayer Healthcare Aktiengesellschaft. His experience in these organizations has allowed him to refine his expertise in the development of pharmaceutical innovations.

Collaborations

Some of his coworkers include Heike Gielen-Haertwig and Volkhart Min-Jian Li. Their collaborative efforts have contributed to the advancement of research in medicinal chemistry.

Conclusion

Swen Allerheiligen is a distinguished inventor whose work in medicinal chemistry has led to significant advancements in the treatment of cardiovascular disorders. His innovative patents and collaborations highlight his commitment to improving healthcare through scientific research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…